Page 4 - Aurinia Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aurinia pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aurinia Pharmaceutical Today - Breaking & Trending Today

Brokers Issue Forecasts for Aurinia Pharmaceuticals Inc.'s Q1 2023 Earnings (NASDAQ:AUPH)

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) – Stock analysts at Oppenheimer issued their Q1 2023 earnings per share estimates for Aurinia Pharmaceuticals in a report issued on Tuesday, February 28th. Oppenheimer analyst J. Kim expects that the biotechnology company will earn ($0.23) per share for the quarter. Oppenheimer has a “Market Perform” rating […] ....

Russia General , United States , Aurinia Pharmaceuticals Inc , Hedge Funds Weigh In On Aurinia Pharmaceuticals , Great West Life Assurance Co , News Ratings For Aurinia Pharmaceuticals Daily , Geneos Wealth Management Inc , Nisa Investment Advisors , Aurinia Pharmaceuticals Trading , Capital Management , Kestra Advisory Services , Aurinia Pharmaceuticals , Royal Bank , Get Rating , Aurinia Pharmaceutical , Investment Advisors , Wealth Management , Advisory Services , West Life Assurance , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph , Earnings Estimates , Oppenheimer Holdings Inc ,

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Expected to Earn Q1 2023 Earnings of ($0.25) Per Share

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) – Analysts at SVB Leerink lifted their Q1 2023 earnings per share estimates for Aurinia Pharmaceuticals in a research note issued on Wednesday, March 1st. SVB Leerink analyst J. Schwartz now expects that the biotechnology company will post earnings per share of ($0.25) for the quarter, up […] ....

United States , Aurinia Pharmaceuticals Inc , Virtu Financial , News Ratings For Aurinia Pharmaceuticals Daily , Aurinia Pharmaceuticals Price Performance , Aurinia Pharmaceuticals Company Profile , Squarepoint Ops , Aurinia Pharmaceuticals , Royal Bank , Get Rating , Aurinia Pharmaceutical , Wisconsin Investment Board , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph , Earnings Estimates , Svb Leerink Llc ,

Brokers Offer Predictions for Aurinia Pharmaceuticals Inc.'s Q1 2023 Earnings (NASDAQ:AUPH)

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP) – Analysts at Jefferies Financial Group issued their Q1 2023 EPS estimates for shares of Aurinia Pharmaceuticals in a report released on Tuesday, February 28th. Jefferies Financial Group analyst M. Raycroft expects that the biotechnology company will earn ($0.21) per share for the quarter. The consensus estimate […] ....

United States , Aurinia Pharmaceuticals Inc , Virtu Financial , Hedge Funds Weigh In On Aurinia Pharmaceuticals , News Ratings For Aurinia Pharmaceuticals Daily , Jefferies Financial Group , Aurinia Pharmaceuticals Trading , Squarepoint Ops , Aurinia Pharmaceuticals , Analysts At Jefferies Financial Group , Royal Bank , Get Rating , Financial Group , Aurinia Pharmaceutical , Wisconsin Investment Board , Pharmaceuticals Inc , Aurinia Pharmaceuticals Daily , Nasdaq Auph , Earnings Estimates , Jefferies Financial Group Inc ,

Why Is Aurinia Pharmaceuticals (AUPH) Stock Down 30%?

Despite strong Q3 earnings, shares of AUPH stock are in steep decline today after it lowered its full-year sales guidance. ....

Aurinia Pharmaceuticals , Aurinia Pharmaceutical ,

InsightAce Analytics Pvt. Ltd.: Rare Kidney Diseases Market to is Projected to Grow at a CAGR of 16%, During the Period 2022-2030, claims InsightAce Analytic

JERSEY CITY, N.J., Oct. 19, 2022 /PRNewswire/ InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global Rare Kidney Diseases Market By Target ....

Coahuila De Zaragoza , United States , New Zealand , South Africa , South Korea , Kostenloser Wertpapierhandel , Asia Pacific , Amicus Therapeutics , Alexion Pharmaceuticals , Reata Pharmaceuticals , Route Of Administration Intravenous , Apellis Pharmaceuticals , Novartis Pharmaceuticals , Protalix Biotherapeutics , European Medicines Agency , Omeros Corporation , Route Of Administration , Ace Analytic , Iga Nephropathy , Membranous Nephropathy , Lupus Nephritis , Focal Segmental Glomerular Sclerosis , Small Molecules , Monoclonal Antibody , Recombinant Protein , Industry Analysis ,